Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1975 Jun;38(6):592–597. doi: 10.1136/jnnp.38.6.592

Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.

D A Drachman, P Y Paterson, R T Schmidt, R F Spehlmann
PMCID: PMC492034  PMID: 1097604

Abstract

Cyclophosphamide (CY) has been shown to reverse the signs of experimental allergic encephalomyelitis (EAE) even after the onset of neurological deficits. Because of the analogy of EAE to exacerbations of multiple sclerosis (MS) a clinical trial of CY in acute MS exacerbations was undertaken. A 'sequential criterion' method was used to minimize the size of sample needed for this pilot study. CY failed to alter significantly the course of acute exacerbations of MS. Possible reasons for this failure, and the value of the sequential criterion method in pilot studies, are discussed.

Full text

PDF
592

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Dickinson J. P. Aetiology of multiple sclerosis. Lancet. 1974 Jun 15;1(7868):1196–1199. doi: 10.1016/s0140-6736(74)91005-8. [DOI] [PubMed] [Google Scholar]
  2. BORNSTEIN M. B., APPEL S. H. TISSUE CULTURE STUDIES OF DEMYELINATION. Ann N Y Acad Sci. 1965 Mar 31;122:280–286. doi: 10.1111/j.1749-6632.1965.tb20212.x. [DOI] [PubMed] [Google Scholar]
  3. BRANDRISS M. W., SMITH J. W., FRIEDMAN R. M. SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITIES. Ann N Y Acad Sci. 1965 Mar 31;122:356–368. doi: 10.1111/j.1749-6632.1965.tb20220.x. [DOI] [PubMed] [Google Scholar]
  4. Field E. J. Cyclophosphamide inhibition of experimental allergic encephalomyelitis in guinea pigs. Arch Int Pharmacodyn Ther. 1969 Nov;182(1):171–177. [PubMed] [Google Scholar]
  5. Gabrielsen A. E., Good R. A. Chemical suppression of adaptive immunity. Adv Immunol. 1967;6:91–229. doi: 10.1016/s0065-2776(08)60522-2. [DOI] [PubMed] [Google Scholar]
  6. Levine S. Relationship of experimental allergic encephalomyelitis to human disease. Res Publ Assoc Res Nerv Ment Dis. 1971;49:33–49. [PubMed] [Google Scholar]
  7. MacFadyen D. J., Reeve C. E., Bratty P. J., Thomas J. W. Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosis. Neurology. 1973 Jun;23(6):592–598. doi: 10.1212/wnl.23.6.592. [DOI] [PubMed] [Google Scholar]
  8. Mackay I. R., Carnegie P. R., Coates A. S. Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis. Clin Exp Immunol. 1973 Dec;15(4):471–482. [PMC free article] [PubMed] [Google Scholar]
  9. Millac P., Miller H. Cyclophosphamide in multiple sclerosis. Lancet. 1969 Apr 12;1(7598):783–783. doi: 10.1016/s0140-6736(69)91788-7. [DOI] [PubMed] [Google Scholar]
  10. Paterson P. Y. Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats. J Immunol. 1971 Jun;106(6):1473–1479. [PubMed] [Google Scholar]
  11. Paterson P. Y., Drobish D. G. Cyclophosphamide: effect on experimental allergic encephalomyelitis in Lewis rats. Science. 1969 Jul 11;165(3889):191–192. doi: 10.1126/science.165.3889.191. [DOI] [PubMed] [Google Scholar]
  12. Paterson P. Y. Multiple sclerosis: an immunologic reassessment. J Chronic Dis. 1973 Mar;26(3):119–126. doi: 10.1016/0021-9681(73)90085-4. [DOI] [PubMed] [Google Scholar]
  13. SCHUMACHER G. A., BEEBE G., KIBLER R. F., KURLAND L. T., KURTZKE J. F., MCDOWELL F., NAGLER B., SIBLEY W. A., TOURTELLOTTE W. W., WILLMON T. L. PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS. Ann N Y Acad Sci. 1965 Mar 31;122:552–568. doi: 10.1111/j.1749-6632.1965.tb20235.x. [DOI] [PubMed] [Google Scholar]
  14. Sheremata W., Cosgrove J. B., Eylar E. H. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis. N Engl J Med. 1974 Jul 4;291(1):14–17. doi: 10.1056/NEJM197407042910104. [DOI] [PubMed] [Google Scholar]
  15. Silberberg D., Lisak R., Zweiman B. Multiple sclerosis unaffected by azathioprine in pilot study. Arch Neurol. 1973 Mar;28(3):210–212. doi: 10.1001/archneur.1973.00490210090017. [DOI] [PubMed] [Google Scholar]
  16. Tourtellotte W. W., Parker J. A. Multiple sclerosis: brain immunoglobulin-G and albumin. Nature. 1967 May 13;214(5089):683–686. doi: 10.1038/214683a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES